Press Releases

  • Intact Vascular Announces Completion of TOBA-BTK Trial Enrollment NOVEMBER 4, 2014 – WAYNE, Pa.– (BUSINESS WIRE)–Intact Vascular, a medical device company and developer of products for minimally invasive peripheral vascular procedures, today announced its completion of the TOBA-BTK Study, Tack Optimized Balloon Angioplasty – Below the Knee Study. This multi-center pilot study focused on gathering data supporting the safety and performance of the Tack ...
  • Intact Vascular, Inc. Strengthens Executive Management Team Adding Bryan A. Claseman as VP of Marketing & Business Development and Marc Penna as VP of Clinical Affairs NOVEMBER 3, 2014 – WAYNE, Pa.–(BUSINESS WIRE)–Intact Vascular, Inc., a developer of medical devices for minimally invasive peripheral vascular procedures, today announced that Bryan A. Claseman and Marc Penna have joined the Company as VP of Marketing & Business Development and VP of Clinical Affairs, respectively. Intact Vascular CEO, Bruce Shook commented, “Bryan and Marc bring ...
  • Intact Vascular, Inc. Hires Bruce Shook as President and Chief Executive Officer JULY 14, 2014 – WAYNE, Pa.–(BUSINESS WIRE)–Intact Vascular, Inc., a developer of medical devices for minimally invasive peripheral vascular procedures, today announced that Bruce J. Shook is joining the Company as President and Chief Executive Officer and as a member of its Board of Directors. Mr. Shook, a highly experienced medical device executive, previously spent ...
  • Intact Vascular, Inc. Hires Joseph Griffin as Vice President of Regulatory Affairs and Quality Assurance FEBRUARY 26, 2014 – WAYNE, Pa.–(BUSINESS WIRE)–Intact Vascular, Inc. today announced the appointment of Joseph C. Griffin to the position of Vice President of Regulatory Affairs and Quality Assurance. Intact Vascular CEO, Carol Burns, commented, “This year our focus is on obtaining FDA IDE approval for our US clinical trial for the Tack-It Endovascular System™. ...
  • Intact Vascular Announces Initiation of the Tack Optimized Balloon Angioplasty Below-the Knee (TOBA- BTK) Study DECEMBER 17, 2013 – WAYNE, Pa.–(BUSINESS WIRE)–Intact Vascular, Inc., a developer of medical devices for minimally invasive peripheral vascular procedures, today announced the start of enrollment in the Tack Optimized Balloon Angioplasty Below the Knee (TOBA-BTK) study. This multi-center pilot study will gather data supporting the safety and performance of the Tack-It Endovascular System™ in ...
  • Intact Vascular Announces Completion of Enrollment of the Tack Optimized Balloon Angioplasty (TOBA) Study OCTOBER 1, 2013 – WAYNE, Pa.–(BUSINESS WIRE)–Intact Vascular, Inc., a developer of medical devices for minimally invasive peripheral vascular procedures, today announced the completion of enrollment of the Tack Optimized Balloon Angioplasty (TOBA) study. The purpose of this multi-center study is to gather confirmatory data on the use of the Tack-It Endovascular System™in the superficial ...
  • Intact Vascular Announces $15.5 MM Series A Financing SEPTEMBER 5, 2012 – WAYNE, Pa.–(BUSINESS WIRE)- Intact Vascular, a medical device company and developer of products for minimally invasive peripheral vascular procedures, today announced the completion of a $15.5 MM Series A financing. The proceeds from this financing will be used to continue clinical studies of the Tack-It Endovascular System™, a novel endovascular stapling ...